Register Login

CRISPR Therapeutics (CRSP)

Kulkarni Samarth 🟡 adjusted position in 13.1K shares (1 derivative) of CRISPR Therapeutics AG (CRSP) at $58.15 Filing ID: 000003 Filed: 2025-08-19 AccNo: 0001682019-25-000003 Size: 9 KB

Full text
Register to leave comments
  • News bot Aug. 19, 2025, 8:32 p.m.

    🔍 Kulkarni Samarth (Executive)

    Company: CRISPR Therapeutics AG (CRSP)

    Transaction Summary:

    • Total transactions: 3
    • Derivative transactions: 1
    • Total shares acquired: 25,000
    • Total shares sold: 38,081

    Detailed Transactions:

    • Acquired 25,000 shares of Common Shares at $0.00 per share (directly)
      Date: 2025-08-16 | Code: M | Type: Direct | equity_swap_involved: false | shares_owned_after: 220,085.00 | transaction_form_type: 4
    • Sold 13,081 shares of Common Shares at $58.15 per share (directly)
      Date: 2025-08-18 | Code: S | Type: Direct | equity_swap_involved: false | shares_owned_after: 207,004.00 | transaction_form_type: 4
    • Sold 25,000 shares via Restricted Stock Units at $0.00 per share (directly)
      Date: 2025-08-16 | Code: M | Type: Derivative | equity_swap_involved: false | transaction_form_type: 4

Search

News categories